Matthew Pruente

Managing Director
15+ years of accounting and healthcare experience
Specializes in M&A integration and performance improvement
Expert in medical group operations, clinical funds flows, and revenue cycle enhancements
Detroit
@alvarezmarsal
LinkedIn
Copied!
Matthew Pruente is a Managing Director with Alvarez & Marsal Healthcare Industry Group in Detroit. He brings more than 15 years of accounting and healthcare experience, specializing in M&A integration, performance improvement, clinical funds flows, and revenue cycle enhancements to the health systems service line.

Mr. Pruente has worked with hospitals to identify cost-reduction opportunities, has led integration operations, and has helped medical centers acquire other hospitals, managing all strategic, regulatory, financial, and operational elements.

Prior to joining A&M, Mr. Pruente served as the Associate Chief Financial Officer for Michigan Medicine, leading finances for the University of Michigan Medical Group (UMMG), a $2+ billion organization. He negotiated and contemporized over $100 million in funds flow arrangements between the clinical enterprise and the clinical departments, established clinical staffing model funds flow arrangements and created and implemented the institution’s first group performance measure to promote contemporary intradepartmental collaboration, and implemented a redesigned financial structure.

Previously, Mr. Pruente served as interim Chief Reporting Officer and Senior Vice President of Financial Planning and Analysis for a $1.3 billion private equity–owned physician services company, serving through two annual budgets, monthly forecasts, monthly operating reporting, and quarterly lender reporting packages.

Mr. Pruente earned a bachelor’s degree in accounting (focus on international business) and a master’s degree in accounting from Michigan State University. He is a registered and licensed Certified Public Accountant (CPA) in the state of Illinois.

Insights By This Professional

The Trump Administration's Executive Order to reduce NIH indirect funding to 15% for institutions conducting medical research including hospitals and universities, has generated significant uncertainty among healthcare providers.
Virtual care is transforming healthcare—making it more accessible, efficient, and cost-effective. In A&M Healthcare Industry Group’s latest podcast, we delve into the evolving reimbursement laws and strategies for generating new revenue streams.
Latest insights The latest insights from Matthew Pruente's team